Rivaroxaban in the treatment of TEK-related venous malformation
Details
Publication Year 2022-08,Volume 63,Issue #3,Page e255-e258
Journal Title
Australasian Journal of Dermatology
Publication Type
Case report
Abstract
Low-flow vascular malformations are rare congenital anomalies due to errors in vascular development and may be associated with known pathogenic genetic variants. Slow flow through the blood vessels can lead to localized intralesional thromboses, which can cause debilitating pain and impair quality of life. We present a case of venous malformation due to a variant in the TEK gene in a 38-year-old woman in whom treatment with low dose rivaroxaban was successful in controlling symptoms of chronic localized intravascular coagulation.
Keywords
Adult; Female; Humans; Pain; Quality of Life; *Rivaroxaban/adverse effects; *Vascular Malformations/complications/drug therapy/genetics; factor Xa inhibitors; genetic testing; mosaicism; rivaroxaban; vascular malformations
Department(s)
Haematology
PubMed ID
35460567
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2025-02-14 04:06:12
Last Modified: 2025-02-14 04:08:15

© 2025 The Walter and Eliza Hall Institute of Medical Research. Access to this website is subject to our Privacy Policy and Terms of Use

An error has occurred. This application may no longer respond until reloaded. Reload 🗙